Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices

Abstract

Background Readmissions following exacerbations of chronic obstructive pulmonary disease (COPD) are prevalent and costly. Multimorbidity is common in COPD and understanding how comorbidity influences readmission risk will enable health systems to manage these complex patients. Objectives We compared two commonly used comorbidity indices published by Charlson and Elixhauser regarding their ability to estimate readmission odds in COPD and determine which one provided a superior model. Methods We analyzed discharge records for COPD from the Nationwide Readmissions Database spanning 2010 to 2016. Inclusion and readmission criteria from the Hospital Readmissions Reduction Program were utilized. Elixhauser and Charlson Comorbidity Index scores were calculated from published methodology. A mixed-effects logistic regression model with random intercepts for hospital clusters was fit for each comorbidity index, including year, patient-level, and hospital-level covariates to estimate odds of thirty-day readmissions. Sensitivity analyses included testing age inclusion thresholds and model stability across time. Results In analysis of 1.6 million COPD discharges, readmission odds increased by 9% for each half standard deviation increase of Charlson Index scores and 13% per half standard deviation increase of Elixhauser Index scores. Model fit was slightly better for the Elixhauser Index using information criteria. Model parameters were stable in our sensitivity analyses. Conclusions Both comorbidity indices provide meaningful information in prediction readmission odds in COPD with slightly better model fit in the Elixhauser model. Incorporation of comorbidity information into risk prediction models and hospital discharge planning may be informative to mitigate readmissions.

<p>Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model</p>

“…28 The relationship between the number of comorbidities and the probability of rehospitalisation has also been reported in a recent study of a Californian hospital admissions database. 29 Similarly, an association between the presence of comorbidities in general and an increased risk of exacerbations has been reported previously. 30 Malnutrition is a characterised consequence of COPD and increases with the severity of COPD.…”

Prognostic Significance of Diastolic Dysfunction With Multiple Comorbidities in Heart Failure Patients

“…Similar findings were seen in a study conducted on national database concluded that higher comorbidity burden as determined by CCI in patients of HF with diastolic dysfunction predicted higher readmission rate at 30 days, as was the renal failure [23]. Similar results were found in a large number of COPD patients in whom CCI provided meaningful prediction for readmission at 30 days [24]. Another large-scale study conducted on the Chinese population determined that higher CCI was independently associated with a risk of 30-day readmission in dialysis patients (both hemodialysis and peritoneal dialysis) [25].…”

Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease

“…Our main independent variable was the Elixhauser Comorbidity Index score, 33 constructed using adaptations of published software, 34,35 having previously validated its use for modeling COPD readmissions. 36 We involved covariates provided with the database, including sociodemographic variables (eg, age, sex, community characteristics, payer, and median income at patient's ZIP code) and hospital characteristics (eg, size, ownership, teaching status). We constructed additional covariates to account for in-hospital events by aggregating ICD diagnosis and procedure codes (eg, mechanical ventilation), hospital discharge volume, and proportion of annual within-hospital Medicaid patient days as a surrogate marker for safety-net hospitals.…”